Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells
- 1 February 2008
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 153 (4) , 805-819
- https://doi.org/10.1038/sj.bjp.0707601
Abstract
Background and purpose: Certain nuclear receptors (NRs) such as the constitutive androstane receptor (CAR), pregnane X receptor (PXR) and farnesoid X receptor (FXR) mediate induction of some cytochrome P450 enzymes and ABC transporters but conflicting reports exist. The purpose of this study was to assess the reasons for these discrepancies and use a standardized approach to compare activators of NRs.Experimental approach: Dexamethasone, pregnenolone 16α‐carbonitrile, rifampicin, phenobarbital and chenodeoxycholic acid were incubated with HepG2, Caco‐2 and cryopreserved human hepatocytes prior to analysis of mRNA and protein for CYP2B6, CYP3A4, CYP3A5, ABCB1, ABCC1, ABCC2, PXR, CAR and FXR.Key results: Dexamethasone significantly up‐regulated PXR, CYP3A4 and ABCB1 expression in HepG2 and Caco‐2 cells. As a result, including dexamethasone as a media supplement masked the induction of these genes by pregnenolone 16α‐carbonitrile, which may explain discrepancies between previous reports. In the absence of dexamethasone, significant activator‐dependent induction was observed in all cell types. Significant correlations were observed between the fold increase in mRNA and in protein, which were, for most instances, logarithmic. Changes in mRNA expression were greater in cell lines than primary cells but for most transcripts correlations were observed between fold increases in HepG2 and hepatocytes.Conclusions and implications: Clearly, noin vitrosystem can imitate the physiology of a hepatocyte or intestinal cell within an intact organin vivo, but these data explain some of the discrepancies reported between laboratories and have important implications for study design.British Journal of Pharmacology(2008)153, 805–819; doi:10.1038/sj.bjp.0707601; published online 26 November 2007Keywords
This publication has 69 references indexed in Scilit:
- Use of Immortalized Human Hepatocytes to Predict the Magnitude of Clinical Drug-Drug Interactions Caused by CYP3A4 InductionDrug Metabolism and Disposition, 2006
- Differential Regulation of Hepatic CYP2B6 and CYP3A4 Genes by Constitutive Androstane Receptor but Not Pregnane X ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Induction of P‐glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elementsBritish Journal of Clinical Pharmacology, 2006
- Preincubation of rat and human hepatocytes with cytoprotectants prior to cryopreservation can improve viability and function upon thawingLiver Transplantation, 2005
- The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristicsCell Biology and Toxicology, 2005
- Regulation of CYP3A4 by the bile acid receptor FXRPharmacogenetics, 2004
- Studies on the induction of rat hepatic CYP1A, CYP2B, CYP3A and CYP4A subfamily form mRNAs in vivo and in vitro using precision-cut rat liver slicesXenobiotica, 2003
- Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL inductionCell Death & Differentiation, 2001
- Regulation by dexamethasone of P‐glycoprotein expression in cultured rat hepatocytesFEBS Letters, 1993
- Optimization of Cryopreservation Procedures for Rat and Human HepatocytesXenobiotica, 1989